Skip to main content
Top
Published in: International Orthopaedics 7/2021

01-07-2021 | Tranexamic Acid | Letter to the Editor

Comment on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”

Authors: Haitao Dong, Yali Lu, Yannian Luo

Published in: International Orthopaedics | Issue 7/2021

Login to get access

Excerpt

Dear Editor: …
Literature
1.
go back to reference Zhang L, Li Y, Liu D et al (2020) Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. Int Orthop 44(10):2079–2087CrossRef Zhang L, Li Y, Liu D et al (2020) Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. Int Orthop 44(10):2079–2087CrossRef
Metadata
Title
Comment on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”
Authors
Haitao Dong
Yali Lu
Yannian Luo
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 7/2021
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-021-05036-y

Other articles of this Issue 7/2021

International Orthopaedics 7/2021 Go to the issue